Jimeno, Antonio <br/><br/>
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  May 2013 
 - 2766-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-3654  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alanine Transaminase--metabolism<br/>Alopecia--chemically induced<br/>Area Under Curve<br/>Aspartate Aminotransferases--metabolism<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Fatigue--chemically induced<br/>Female<br/>Follow-Up Studies<br/>Hedgehog Proteins--metabolism<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neoplasms--drug therapy<br/>Signal Transduction--drug effects<br/>Spasm--chemically induced<br/>Treatment Outcome<br/>Veratrum Alkaloids--adverse effects